One of the listed companies, Indo-Bangla Pharmaceuticals Limited, discloses its financial reports for the first quarter, (July–September 22). This source is known from DSE.
The company’s earnings per share (EPS) of Tk 0.17 paisa in Q1 of the current financial year. EPS of Tk 0.33 paisa during the same period last year. As of September 30, 2022, the net asset value (NAVPS) was Tk 14.16 paisa.
/NR
Share this
